Search

everythinglearnresearchcommunity

for

Search:↓

Human hair-derived particles can effectively carry and release the cancer drug Paclitaxel in a pH-sensitive manner, potentially targeting cancer cells while sparing healthy ones.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

The CNC® prosthetic system improved body image in breast cancer patients with hair loss from chemotherapy but did not significantly change their psychological wellbeing.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

A woman with breast cancer developed a rare condition causing excessive fine hair growth on her face and body.

Blocking YAP/TAZ could be a new way to treat skin cancer.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

A new method accurately measures nine specific hormones in human blood.

Lower SMAD2/3 activation predicts more severe skin cancer.

Mutations in certain receptors can cause diseases and offer new treatment options.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

Hinokiflavone may help treat cancers and other health issues.

HPV genes and estradiol increase a cancer-related signaling pathway, which may be targeted for cervical cancer treatment.

Septin4 helps kill colon cancer cells by working with the protein BAX.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Paclitaxel is an effective cancer drug with side effects and potential new uses beyond cancer.

A 50-year-old woman with breast cancer developed an autoimmune skin disorder, highlighting the need for thorough checks and team-based treatment.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Combining soursop leaf extract with doxorubicin may improve breast cancer treatment and reduce side effects.

The May issue discussed publishing agreements and four studies on cholesterol in hair, cancer cell changes, hormones in the uterus, and skin protein effects.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.

Vitamin C was found to effectively treat prickly heat in children.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

Certain spices may help prevent and treat skin cancer, but more human trials are needed.